Modulation of toxin stability by 4-phenylbutyric acid and negatively charged phospholipids

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Ray, Supriyo ^a,b   Taylor, Michael ^b   Burlingame, Mansfield ^b,c   Tatulian, Suren A ^a   Teter, Ken ^b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^c Lake Brantley High School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 PALMITOYL 2 OLEOYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 OLEOYL SN GLYCERO 3 PHOSPHOGLYCEROL; 4 PHENYLBUTYRIC ACID; CHOLERA TOXIN; CHOLERA TOXIN A1 CHAIN; GLYCEROL; PHOSPHOLIPID; RICIN; RICIN TOXIN A CHAIN; UNCLASSIFIED DRUG; VACCINE; 4-PHENYLBUTYRIC ACID; ANION; ARYLBUTYRIC ACID DERIVATIVE; MEMBRANE LIPID; TOXIN;

ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CYTOSOL; DISSOCIATION; DRUG STABILITY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; INTRACELLULAR TRANSPORT; MOLECULAR STABILITY; PH; PHOSPHOLIPID MEMBRANE; PHOSPHOLIPID VESICLE; PROTEIN DOMAIN; PROTEIN TRANSPORT; PROTEIN UNFOLDING; TEMPERATURE; THERMOSTABILITY; TOXIN STRUCTURE; ANIMAL; CERCOPITHECUS; CHEMISTRY; DRUG EFFECT; INTRACELLULAR MEMBRANE; PROTEIN STABILITY; VERO CELL;

ANIMALS; ANIONS; CERCOPITHECUS AETHIOPS; ENDOPLASMIC RETICULUM; INTRACELLULAR MEMBRANES; MEMBRANE LIPIDS; PHENYLBUTYRATES; PHOSPHOLIPIDS; PROTEIN STABILITY; PROTEIN TRANSPORT; PROTEIN UNFOLDING; RICIN; TOXINS, BIOLOGICAL; VERO CELLS;

EID: 80051918967     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023692     Document Type: Article

References (57)

1. Sandvig K, van Deurs B, (2002) Membrane traffic exploited by protein toxins. Annu Rev Cell Dev Biol 18: 1-24.
2. Lord JM, Roberts LM, Lencer WI, (2005) Entry of protein toxins into mammalian cells by crossing the endoplasmic reticulum membrane: co-opting basic mechanisms of endoplasmic reticulum-associated degradation. Curr Top Microbiol Immunol 300: 149-168.
3. Spooner RA, Watson PD, Marsden CJ, Smith DC, Moore KA, et al. (2004) Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum. Biochem J 383: 285-293.
4. Hazes B, Boodhoo A, Cockle SA, Read RJ, (1996) Crystal structure of the pertussis toxin-ATP complex: a molecular sensor. J Mol Biol 258: 661-671.
5. Majoul I, Ferrari D, Soling HD, (1997) Reduction of protein disulfide bonds in an oxidizing environment. The disulfide bridge of cholera toxin A-subunit is reduced in the endoplasmic reticulum. FEBS Lett 401: 104-108.
6. Orlandi PA, (1997) Protein-disulfide isomerase-mediated reduction of the A subunit of cholera toxin in a human intestinal cell line. J Biol Chem 272: 4591-4599.
7. Tsai B, Rodighiero C, Lencer WI, Rapoport TA, (2001) Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 104: 937-948.
8. Brodsky JL, (2007) The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation). Biochem J 404: 353-363.
9. Deeks ED, Cook JP, Day PJ, Smith DC, Roberts LM, et al. (2002) The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol. Biochemistry 41: 3405-3413.
10. Hazes B, Read RJ, (1997) Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 36: 11051-11054.
11. Rodighiero C, Tsai B, Rapoport TA, Lencer WI, (2002) Role of ubiquitination in retro-translocation of cholera toxin and escape of cytosolic degradation. EMBO Rep 3: 1222-1227.
12. Worthington ZE, Carbonetti NH, (2007) Evading the proteasome: absence of lysine residues contributes to pertussis toxin activity by evasion of proteasome degradation. Infect Immun 75: 2946-2953.
13. Pande AH, Moe D, Jamnadas M, Tatulian SA, Teter K, (2006) The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome. Biochemistry 45: 13734-13740.
14. Pande AH, Scaglione P, Taylor M, Nemec KN, Tuthill S, et al. (2007) Conformational instability of the cholera toxin A1 polypeptide. J Mol Biol 374: 1114-1128.
15. Ampapathi RS, Creath AL, Lou DI, Craft JW Jr, Blanke SR, et al. (2008) Order-disorder-order transitions mediate the activation of cholera toxin. J Mol Biol 377: 748-760.
16. Argent RH, Parrott AM, Day PJ, Roberts LM, Stockley PG, et al. (2000) Ribosome-mediated folding of partially unfolded ricin A-chain. J Biol Chem 275: 9263-9269.
17. Olson MA, Carra JH, Roxas-Duncan V, Wannemacher RW, Smith LA, et al. (2004) Finding a new vaccine in the ricin protein fold. Protein Eng Des Sel 17: 391-397.
18. Peek LJ, Brey RN, Middaugh CR, (2007) A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine. J Pharm Sci 96: 44-60.
19. Day PJ, Pinheiro TJ, Roberts LM, Lord JM, (2002) Binding of ricin A-chain to negatively charged phospholipid vesicles leads to protein structural changes and destabilizes the lipid bilayer. Biochemistry 41: 2836-2843.
20. Mayerhofer PU, Cook JP, Wahlman J, Pinheiro TT, Moore KA, et al. (2009) Ricin A chain insertion into endoplasmic reticulum membranes is triggered by a temperature increase to 37 {degrees}C. J Biol Chem 284: 10232-10242.
21. Simpson JC, Lord JM, Roberts LM, (1995) Point mutations in the hydrophobic C-terminal region of ricin A chain indicate that Pro250 plays a key role in membrane translocation. Eur J Biochem 232: 458-463.
22. LaPointe P, Wei X, Gariepy J, (2005) A role for the protease-sensitive loop region of Shiga-like toxin 1 in the retrotranslocation of its A1 domain from the endoplasmic reticulum lumen. J Biol Chem 280: 23310-23318.
23. Menikh A, Saleh MT, Gariepy J, Boggs JM, (1997) Orientation in lipid bilayers of a synthetic peptide representing the C-terminus of the A1 domain of shiga toxin. A polarized ATR-FTIR study. Biochemistry 36: 15865-15872.
24. Saleh MT, Ferguson J, Boggs JM, Gariepy J, (1996) Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes. Biochemistry 35: 9325-9334.
25. Suhan ML, Hovde CJ, (1998) Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity. Infect Immun 66: 5252-5259.
26. Orlandi PA, Curran PK, Fishman PH, (1993) Brefeldin A blocks the response of cultured cells to cholera toxin. Implications for intracellular trafficking in toxin action. J Biol Chem 268: 12010-12016.
27. Lencer WI, Strohmeier G, Moe S, Carlson SL, Constable CT, et al. (1995) Signal transduction by cholera toxin: processing in vesicular compartments does not require acidification. Am J Physiol 269: G548-557.
28. Yoshida T, Chen CH, Zhang MS, Wu HC, (1990) Increased cytotoxicity of ricin in a putative Golgi-defective mutant of Chinese hamster ovary cell. Exp Cell Res 190: 11-16.
29. Lord JM, Spooner RA, (2011) Ricin trafficking in plant and mammalian cells. Toxins 3: 787-801.
30. Wernick NLB, Chinnapen DJ-F, Cho JA, Lencer WI, (2010) Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum. Toxins 2: 310-325.
31. Wu MM, Llopis J, Adams SR, McCaffery JM, Teter K, et al. (2000) Studying organelle physiology with fusion protein-targeted avidin and fluorescent biotin conjugates. Methods Enzymol 327: 546-564.
32. Kim JH, Johannes L, Goud B, Antony C, Lingwood CA, et al. (1998) Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. Proc Natl Acad Sci U S A 95: 2997-3002.
33. Goins B, Freire E, (1988) Thermal stability and intersubunit interactions of cholera toxin in solution and in association with its cell-surface receptor ganglioside GM1. Biochemistry 27: 2046-2052.
34. Jackson LS, Tolleson WH, Chirtel SJ, (2006) Thermal Inactivation of Ricin Using Infant Formula as a Food Matrix. J Agric Food Chem 54: 7300-7304.
35. Massey S, Banerjee T, Pande AH, Taylor M, Tatulian SA, et al. (2009) Stabilization of the tertiary structure of the cholera toxin A1 subunit inhibits toxin dislocation and cellular intoxication. J Mol Biol 393: 1083-1096.
36. Banerjee T, Pande A, Jobling MG, Taylor M, Massey S, et al. (2010) Contribution of subdomain structure to the thermal stability of the cholera toxin A1 subunit. Biochemistry 49: 8839-8846.
37. Presley JF, Mayor S, Dunn KW, Johnson LS, McGraw TE, et al. (1993) The End2 mutation in CHO cells slows the exit of transferrin receptors from the recycling compartment but bulk membrane recycling is unaffected. J Cell Biol 122: 1231-1241.
38. Audi J, Belson M, Patel M, Schier J, Osterloh J, (2005) Ricin poisoning: a comprehensive review. JAMA 294: 2342-2351.
39. O'Hare M, Roberts LM, Thorpe PE, Watson GJ, Prior B, et al. (1987) Expression of ricin A chain in Escherichia coli. FEBS Lett 216: 73-78.
40. Piatak M, Lane JA, Laird W, Bjorn MJ, Wang A, et al. (1988) Expression of soluble and fully functional ricin A chain in Escherichia coli is temperature-sensitive. J Biol Chem 263: 4837-4843.
41. Brandau DT, Jones LS, Wiethoff CM, Rexroad J, Middaugh CR, (2003) Thermal stability of vaccines. J Pharm Sci 92: 218-231.
42. Compton JR, Legler PM, Clingan BV, Olson MA, Millard CB, (2010) Introduction of a disulfide bond leads to stabilization and crystallization of a ricin immunogen. Proteins 79: 1048-1060.
43. Smallshaw JE, Richardson JA, Pincus S, Schindler J, Vitetta ES, (2005) Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. Vaccine 23: 4775-4784.
44. Vitetta ES, Smallshaw JE, Coleman E, Jafri H, Foster C, et al. (2006) A pilot clinical trial of a recombinant ricin vaccine in normal humans. Proc Natl Acad Sci U S A 103: 2268-2273.
45. Smallshaw JE, Vitetta ES, (2010) A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity. Vaccine 28: 2428-2435.
46. Maestri NE, Brusilow SW, Clissold DB, Bassett SS, (1996) Long-term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med 335: 855-859.
47. Taylor M, Banerjee T, Navarro-Garcia F, Huerta J, Massey S, et al. (2011) A therapeutic chemical chaperone inhibits cholera intoxication and unfolding/translocation of the cholera toxin A1 subunit. PLoS ONE 6: e18825.
48. Myszka DG, (1997) Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Curr Opin Biotechnol 8: 50-57.
49. Massey S, Quinones B, Teter K, (2011) A Cell-Based Fluorescent Assay to Detect the Activity of Shiga Toxin and Other Toxins that Inhibit Protein Synthesis. Methods Mol Biol 739: 49-59.
50. Quinones B, Massey S, Friedman M, Swimley MS, Teter K, (2009) Novel cell-based method to detect Shiga toxin 2 from Escherichia coli O157:H7 and inhibitors of toxin activity. Appl Environ Microbiol 75: 1410-1416.
51. Wawrzynczak EJ, Drake AF, Thorpe PE, (1988) Circular dichroism of isolated ricin A- and B-chains. Biophys Chem 31: 301-305.
52. Sreerama N, Woody RW, (2000) Circular dichroism of peptides and proteins., in Circular Dichroism: Principles and Applications In: Berova N, Nakanishi, K, Woody RW, editors. Hoboken, NJ John Wiley & Sons, Inc pp. 601-620 and.
53. Rutenber E, Katzin BJ, Ernst S, Collins EJ, Mlsna D, et al. (1991) Crystallographic refinement of ricin to 2.5 A. Proteins 10: 240-250.
54. Sandvig K, Madshus IH, Olsnes S, (1984) Dimethyl sulphoxide protects cells against polypeptide toxins and poliovirus. Biochem J 219: 935-940.
55. Guerra L, Teter K, Lilley BN, Stenerlow B, Holmes RK, et al. (2005) Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol 7: 921-934.
56. Guerra L, Nemec KN, Massey S, Tatulian SA, Thelestam M, et al. (2009) A novel mode of translocation for cytolethal distending toxin. Biochim Biophys Acta 1793: 489-495.
57. Perlmutter DH, (2002) Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediatr Res 52: 832-836.